Ozagrel hydrochloride

CAS No. 78712-43-3

Ozagrel hydrochloride( —— )

Catalog No. M15964 CAS No. 78712-43-3

Ozagrel HCl is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
25MG 42 In Stock
50MG 66 In Stock
100MG 100 In Stock
200MG Get Quote In Stock
500MG 253 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ozagrel hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Ozagrel HCl is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.
  • Description
    Ozagrel HCl is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Thrombin
  • Recptor
    Thromboxane A2 synthetase
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    78712-43-3
  • Formula Weight
    264.71
  • Molecular Formula
    C13H12N2O2·HCl
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 6 mg/mL (22.66 mM); Water: 53 mg/mL (200.21 mM); DMSO: 53 mg/mL (200.21 mM)
  • SMILES
    C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ishitsuka Y, et al. J Pharmacol Sci, 2009, 111(2), 211-215.
molnova catalog
related products
  • Dabigatran ethyl est...

    Dabigatran ethyl ester hydrochloride is an effective inhibitor of ribosyl dihydronicotinic acid amide dehydrogenase (NQO2) with an IC50 value of 0.8 μM and is a thrombin inhibitor.

  • AZD-8165

    AZD-8165 is a potent, selective and oral thrombin inhibitor for treatment of thrombosis.

  • Etamsylate

    Ethamsylate is a haemostatic drug, which inhibits biosynthesis and action of prostaglandins, and increases capillary endothelial resistance as and platelet adhesion.